Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Low-dose Primaquine Efficacy and Safety in Malaria
NCT03352843Phase 4Completed
- Sponsor
- Tropical Pesticides Research Institute
- Start
- Jun 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of primaquine in Plasmodium falciparum malaria, sponsored by Tropical Pesticides Research Institute. Primary endpoint: Safety of single low-dose primaquine at 6 months. Started Jun 2019; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT03352843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03352843.